STK17B
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
serine/threonine kinase 17b | MIM:604727 | Ensembl:ENSG00000081320 | HGNC:HGNC:11396 | PA36204 | 2q32.3 |
GO terms in STK17B
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | ISS | GO:0004672 | protein kinase activity |
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
MF | IBA | GO:0005524 | ATP binding |
MF | IDA | GO:0005524 | ATP binding |
BP | IDA | GO:0006468 | protein phosphorylation |
BP | IEA | GO:0006915 | apoptotic process |
BP | IDA | GO:0035556 | intracellular signal transduction |
BP | ISS | GO:0046777 | protein autophosphorylation |
BP | IMP | GO:2000271 | positive regulation of fibroblast apoptotic process |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IEA | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment |
CC | IEA | GO:0005886 | plasma membrane |
CC | IEA | GO:0015629 | actin cytoskeleton |
Gene expression in normal tissue: STK17B
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in STK17B
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD280 | CYTOCHALASIN B | 3 |
iGMDRD300 | Tozasertib | 3 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD398 | Sepantronium | 6 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD351 | GW843682X | 3 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD427 | ABT737 | 3 |
iGMDRD77 | Itraconazole | 3 |
iGMDRD202 | Curcumin | 3 |
iGMDRD126 | Tipifarnib | 3 |
iGMDRD584 | VER 155008 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in STK17B